Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.

Saved in:
Bibliographic Details
Title: Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.
Authors: Matschiner G; Pieris Pharmaceuticals, Hallbergmoos, Germany. Electronic address: matschiner@pieris.com., Fitzgerald MF; Pieris Pharmaceuticals, Hallbergmoos, Germany., Moebius U; Pieris Pharmaceuticals, Hallbergmoos, Germany., Hohlbaum AM; Pieris Pharmaceuticals, Hallbergmoos, Germany., Gille H; Pieris Pharmaceuticals, Hallbergmoos, Germany., Jensen K; Pieris Pharmaceuticals, Hallbergmoos, Germany., Kirchfeld K; Pieris Pharmaceuticals, Hallbergmoos, Germany., Rattenstetter B; Pieris Pharmaceuticals, Hallbergmoos, Germany., Laforge A; Pieris Pharmaceuticals, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals, Hallbergmoos, Germany., Ciccotosto J; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia., Nyugen H; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia., Foster ML; Experimental Pathology Consultancy, Benfleet, United Kingdom., Snouwaert JN; University of North Carolina, Chapel Hill, NC., Nguyen M; University of North Carolina, Chapel Hill, NC., Koller BH; University of North Carolina, Chapel Hill, NC., Matis L; Pieris Pharmaceuticals, Boston, Mass., Anderson GP; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Electronic address: gpa@unimelb.edu.au., Olwill SA; Pieris Pharmaceuticals, Hallbergmoos, Germany.
Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Apr; Vol. 151 (4), pp. 966-975. Date of Electronic Publication: 2022 Dec 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36592703
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matschiner+G%22">Matschiner G</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany. Electronic address: matschiner@pieris.com.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+MF%22">Fitzgerald MF</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Moebius+U%22">Moebius U</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Hohlbaum+AM%22">Hohlbaum AM</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Gille+H%22">Gille H</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Jensen+K%22">Jensen K</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Kirchfeld+K%22">Kirchfeld K</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Rattenstetter+B%22">Rattenstetter B</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Laforge+A%22">Laforge A</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Bel+Aiba+RS%22">Bel Aiba RS</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Ciccotosto+J%22">Ciccotosto J</searchLink>; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Nyugen+H%22">Nyugen H</searchLink>; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Foster+ML%22">Foster ML</searchLink>; Experimental Pathology Consultancy, Benfleet, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Snouwaert+JN%22">Snouwaert JN</searchLink>; University of North Carolina, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Nguyen+M%22">Nguyen M</searchLink>; University of North Carolina, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Koller+BH%22">Koller BH</searchLink>; University of North Carolina, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Matis+L%22">Matis L</searchLink>; Pieris Pharmaceuticals, Boston, Mass.<br /><searchLink fieldCode="AU" term="%22Anderson+GP%22">Anderson GP</searchLink>; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Electronic address: gpa@unimelb.edu.au.<br /><searchLink fieldCode="AU" term="%22Olwill+SA%22">Olwill SA</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%221275002%22">The Journal of allergy and clinical immunology</searchLink> [J Allergy Clin Immunol] 2023 Apr; Vol. 151 (4), pp. 966-975. <i>Date of Electronic Publication: </i>2022 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>1275002 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6825 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200916749%22">00916749 </searchLink><i>NLM ISO Abbreviation: </i>J Allergy Clin Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36592703
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jaci.2022.12.815
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 966
    Titles:
      – TitleFull: Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matschiner G
      – PersonEntity:
          Name:
            NameFull: Fitzgerald MF
      – PersonEntity:
          Name:
            NameFull: Moebius U
      – PersonEntity:
          Name:
            NameFull: Hohlbaum AM
      – PersonEntity:
          Name:
            NameFull: Gille H
      – PersonEntity:
          Name:
            NameFull: Jensen K
      – PersonEntity:
          Name:
            NameFull: Kirchfeld K
      – PersonEntity:
          Name:
            NameFull: Rattenstetter B
      – PersonEntity:
          Name:
            NameFull: Laforge A
      – PersonEntity:
          Name:
            NameFull: Bel Aiba RS
      – PersonEntity:
          Name:
            NameFull: Ciccotosto J
      – PersonEntity:
          Name:
            NameFull: Nyugen H
      – PersonEntity:
          Name:
            NameFull: Foster ML
      – PersonEntity:
          Name:
            NameFull: Snouwaert JN
      – PersonEntity:
          Name:
            NameFull: Nguyen M
      – PersonEntity:
          Name:
            NameFull: Koller BH
      – PersonEntity:
          Name:
            NameFull: Matis L
      – PersonEntity:
          Name:
            NameFull: Anderson GP
      – PersonEntity:
          Name:
            NameFull: Olwill SA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2023 Apr
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1097-6825
          Numbering:
            – Type: volume
              Value: 151
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The Journal of allergy and clinical immunology
              Type: main
ResultId 1